Back |
home / stock / gthx / gthx message board
Subject | By | Source | When |
---|---|---|---|
I am a physician and I can tell | PRED2020 | investorshub | 12/01/2020 6:22:19 PM |
Jack Baily Head of $GSK USA including their | PRED2020 | investorshub | 12/01/2020 6:21:43 PM |
Looks like this will be a perfect candidate | PRED2020 | investorshub | 12/01/2020 5:37:08 PM |
Looks like the twitter pump failed and is | SurgeGuy2.0 | investorshub | 12/01/2020 3:52:39 PM |
znewcar1: GTHX 27% v5,4M c18.26 f38,0M H18.65 S17.43 | znewcar1 | investorshangout | 11/30/2020 9:53:46 PM |
Should be a good stock for the long | PRED2020 | investorshub | 11/30/2020 7:00:16 PM |
News, Short Squeeze, Breakout and More Instantly...
G1 Therapeutics, Inc. (NASDAQ:GTHX) shares are trading higher Thursday amid M&A blog speculation of a takeover offer. What To Know: Accor...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
- Achieved $14.1 Million in Net Revenue from Sales of COSELA® (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib in Combination with a TROP2 Antibod...